Literature DB >> 25263633

Lupus miliaris disseminatus faciei treated with 1,565 nm nonablative fractionated laser resurfacing: a case report.

Katie Beleznay1, Daniel P Friedmann, Ana Marie Liolios, Adam Perry, Mitchel P Goldman.   

Abstract

BACKGROUND: Lupus miliaris disseminatus faciei (LMDF) is a rare granulomatous disease. It presents as red-brown papules on the face that can resolve with scarring. LMDF is often resistant to treatment.
OBJECTIVE: Nonablative fractionated lasers have been used effectively to treat granulomatous disorders; however, there is little data on the treatment of LMDF with lasers. Our objective was to test a novel non-ablative fractionated laser for the treatment of recalcitrant LMDF.
RESULTS: A 24-year-old man had a one-year history of LMDF. He had been treated with various topical therapies, oral medications, and laser devices with no improvement and continued progression. We utilized a non-sequential scanning 1,565 nm nonablative fractionated laser to treat this patient. After only one treatment he had significant improvement. He has been subsequently treated five times in the past 6 months and has continued to improve.
CONCLUSION: The novel 1,565 nm nonablative fractionated laser may be a useful tool in the treatment of granulomatous conditions such as LMDF.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  laser; lupus miliaris disseminatus faciei; nonablative

Mesh:

Year:  2014        PMID: 25263633     DOI: 10.1002/lsm.22295

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  1 in total

1.  Lupus miliaris disseminatus faciei.

Authors:  Helena Toda-Brito; João Manuel Pires Aranha; Ermelindo Silva Tavares
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.